Valtrex Pregnancy and Breastfeeding: Safety Questions
Valtrex pregnancy and breastfeeding decisions weigh the infection, treatment timing, available human data, maternal kidney function, infant factors, and alternative approaches. A general safety statement cannot replace an individualized discussion with the prescribing clinician.
Medically reviewed for pregnancy and medication safety
Professor of Medicine; Co-Director, Center for Drug Safety and Effectiveness; Director, Pharmacoepidemiology Program, Johns Hopkins Medicine
Reviewed · This check applies to this page version.
Valtrex in pregnancy and breastfeeding requires an individual clinical decision. The current U.S. label says available data over several decades have not identified a drug-associated risk of major birth defects, but data are insufficient for miscarriage and other maternal or fetal outcomes. It also notes that untreated herpes infection can carry pregnancy risks.
Do not start, stop, or change valacyclovir because of a general safety summary. The diagnosis, timing in pregnancy, kidney function, and reason for treatment belong in the same conversation.
Valtrex pregnancy and breastfeeding questions for the prescriber
The April 2026 DailyMed label summarizes clinical experience with valacyclovir and its active metabolite, acyclovir. It states that the available human data have not identified a medicine-associated risk of major birth defects. It also states that evidence is insufficient to draw conclusions about miscarriage or other adverse maternal or fetal outcomes.
Those two statements must be kept together. “No identified risk” is not the same as a guarantee of no risk, and “insufficient data” does not mean a medicine is known to be harmful. A clinician weighs what is known about treatment against the consequences of leaving the infection untreated.
Questions about Valtrex pregnancy and breastfeeding
| Context | What is known | Why an individual check still matters |
|---|---|---|
| Pregnancy | Available human data over several decades have not identified a drug-associated risk of major birth defects. | The label says evidence is insufficient for conclusions about miscarriage and other maternal or fetal outcomes. Timing, diagnosis, and competing infection risk matter. |
| Herpes infection | Untreated herpes simplex during pregnancy can itself carry fetal and newborn risks. | A first episode, a recurrence, and genital symptoms near delivery do not create the same clinical situation. |
| Breastfeeding | Valacyclovir was not detected in the milk data summarized in the label; its active metabolite, acyclovir, was present. | The label has no data on effects on the breastfed child or milk production. The infant’s age and health and the mother’s clinical need should be considered. |
| Kidney function and hydration | Reduced renal clearance can increase valacyclovir exposure, and the label warns about acute kidney injury and central nervous system effects. | Kidney disease, dialysis, dehydration, vomiting, fluid restriction, and other potentially nephrotoxic medicines change the safety conversation. |
Why the infection itself matters
Valacyclovir is a prescription antiviral with adult label indications that include cold sores, genital herpes, and shingles. Pregnancy decisions differ because these conditions do not carry the same maternal, fetal, or newborn concerns. The label specifically notes fetal risks associated with untreated herpes simplex during pregnancy.
Tell the obstetric clinician when symptoms began, whether this is a first episode or a recurrence, and whether there are genital symptoms near delivery. A webpage cannot diagnose an outbreak or decide the urgency of treatment.
Breastfeeding and acyclovir exposure
Valacyclovir itself was not detected in the human-milk data summarized in the label, but its metabolite acyclovir is present in breast milk after oral valacyclovir. The label says there are no data on effects of valacyclovir or acyclovir on the breastfed child or on milk production.
The recommended decision framework is to consider the developmental and health benefits of breastfeeding, the mother’s clinical need for treatment, and possible adverse effects from the medicine or the underlying condition. That balance should involve the prescriber and, when appropriate, the child’s clinician.
Medication-check steps before a decision
- Confirm the reason for treatment. Record the suspected condition, where symptoms are located, when they started, and whether this is a first episode or a recurrence.
- Place the decision in pregnancy or feeding context. Share the stage of pregnancy, proximity to delivery, or the breastfed child’s age, prematurity, and current health concerns.
- check kidney and hydration factors. Include kidney disease, dialysis, recent renal results, vomiting, poor fluid intake, and any fluid restriction.
- Reconcile every medicine. Bring prescription medicines, nonprescription products, and supplements, with special attention to medicines that may affect the kidneys.
- Check allergy and reaction history. Report any previous reaction to valacyclovir, acyclovir, or a formulation ingredient.
- Agree on follow-up. Ask which symptoms require a routine call, a prompt same-day check, or emergency care, and which clinician should coordinate the plan.
The official label says no clinically significant drug-drug or drug-food interactions with valacyclovir are known, while also warning about other potentially nephrotoxic medicines. Pregnancy and breastfeeding do not remove the need for a full medication and kidney check.
Who should not rely on this page alone
- Anyone with a first genital-herpes episode during pregnancy.
- Patients with symptoms close to delivery.
- People with reduced kidney function or dialysis treatment.
- Those with repeated vomiting or inability to maintain hydration.
- Anyone with a serious previous reaction to valacyclovir or acyclovir.
Valacyclovir is contraindicated after a clinically significant hypersensitivity reaction to valacyclovir, acyclovir, or a formulation ingredient. New hives, facial or throat swelling, breathing difficulty, or faintness requires urgent assessment. check the Valtrex allergic-reaction steps for the emergency pattern.
Kidney function can affect valacyclovir exposure. The Valtrex kidney-safety page explains the renal and hydration questions without giving a dosing schedule.
Back to the Valtrex safety topic
The Valtrex side-effects overview connects pregnancy and breastfeeding with common adverse effects, kidney risk, and allergy. ARTICLE pages link to this overview rather than directly to the prescription prescription page.
Official source
Source: DailyMed valacyclovir prescribing information, revised April 2026, sections on pregnancy, lactation, warnings, and contraindications.